Plus Therapeutics, Inc. (NASDAQ:PSTV) Q2 2023 Earnings Call Transcript August 14, 2023
Plus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $1.91.
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Second Quarter 2023 Results Conference Call. Before we begin, we want to advise you that over the course of the call and question-and-answer session, forward-looking statements will be made regarding events, trends,...
